19 trials (keyword fallback)
Ventral Hernias
Primary: Visual Analog Scale of Pain Activity — 50; 70 units on a scale
Breast Cancer · Mastectomy
Primary: Patient Comfort Scale — 3; 3 units on a scale — p=0.490
Breast-cancer
Primary: Seroma Formation — 54.27; 59.56; 102.21; 117.94 ml — p=<0.005
Wound Infections
Primary: Number of Participants With Composite Surgical Site Infection (SSI) or Other Wound Complication. — 5; 3 Participants — p=0.72
Dexamethasone · Glucocorticoids · Mastectomy
Primary: Transfer to Post-anesthesia Care Unit (PACU) — 23; 23 Participants — p=1
Breast Cancer
Primary: Seroma Formation — 770.48; 1089.51 ml
Seroma
Primary: Total Drain Output — 284; 317 ml
Seroma
Primary: Number of Participants With Seroma Formation — 2; 8 participants — p=0.022
Coronary Bypass Graft Stenosis of Autologous Vein
Primary: Early Complications of Vascular Zone — 1; 4; 15; 5 participants — p=0.05
Breast Reconstruction
Primary: Postoperative Duration of Drain Placements — 9.2; 10.8 days — p=0.15
Thyroid Neoplasm · Goiter
Primary: To Compare the Amount of Post-operative Wound Drainage Between the Group of Patients in Which EVICEL™ Spray is Utilized (Arm A), and the Group of Patients in Which an…
Infection of Total Hip Joint Prosthesis
Primary: Number of Participants With Hospital Readmissions — 15; 3 Participants
Postoperative Complications
Primary: Proportion of Subjects Who Experience Hernia Recurrence (Defect Treated Initially With Parietex™ ProGrip™) Within 12 Months Post-surgery. — 3 participants
Seroma · Wound Dehiscence · Wound Infection
Primary: Post-operative Seroma Formation — 16.9; 10.1 cm^3
Hernia, Ventral
Primary: The Frequency of Hernia Recurrence Diagnosed by Physical Exam or CT Scan (if Clinically Indicated) — 1 Participants